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After stroke the central nervous system reveals a spectrum of intrinsic capacities to
react as a highly dynamic system which can change the properties of its circuits,
form new contacts, erase others, and remap related cortical and spinal cord regions.
This plasticity can lead to a surprising degree of spontaneous recovery. It includes the
activation of neuronal molecular mechanisms of growth and of extrinsic growth promoting
factors and guidance signals in the tissue. Rehabilitative training and pharmacological
interventions may modify and boost these neuronal processes, but almost nothing is
known on the optimal timing of the different processes and therapeutic interventions and
on their detailed interactions. Finding optimal rehabilitation paradigms requires an optimal
orchestration of the internal processes of re-organization and the therapeutic interventions
in accordance with defined plastic time windows. In this review we summarize the
mechanisms of spontaneous plasticity after stroke and experimental interventions to
enhance growth and plasticity, with an emphasis on anti-Nogo-A immunotherapy. We
highlight critical time windows of growth and of rehabilitative training and consider different
approaches of combinatorial rehabilitative schedules. Finally, we discuss potential future
strategies for designing repair and rehabilitation paradigms by introducing a “3 step
model”: determination of the metabolic and plastic status of the brain, pharmacological
enhancement of its plastic mechanisms, and stabilization of newly formed functional
connections by rehabilitative training.
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INTRODUCTION
The human brain works wonders to fulfill the requirements of
every-day life. These unique capacities are then fully esteemed
when all of a sudden even simple activities fail or become
a problem: cerebral strokes leave the victims with often large
psychical and physical impairments—from vision problems to
aphasia and motor deficits—leading to the number one cause of
adult disability worldwide with great impact on public health.
In the acute phase, “time is brain”—ruptured blood vessels
(hemorrhagic stroke) or aggregates of platelets and blood cells
that clog cerebral blood vessels (ischemic stroke) cause acute
shortage of glucose and oxygen resulting in metabolic distress
and long-term neuronal cell loss. The destruction process is
complex and can only be dampened in the case of the ischemic
stroke by very early intervention (within 4–6 h) with throm-
bolysis, (Hacke et al., 2008). Currently, only about 10% of all
stroke patients reach a hospital early enough or fulfill the cri-
teria for being able to receive thrombolysis in the therapeu-
tic time window. Prognosis and recovery then depend on the
location and extent of the stroke lesion. Clinically, the most
successful therapy to further enhance this recovery of function
is rehabilitative training. Rehabilitation as a term “to reach and
maintain optimal functioning in physical, intellectual, psycholog-
ical and/or social domains” (WHO. International classification
of functioning disability Health ICF. Geneva: WHO; 2001) is
evidence based medicine and does not exclude a specific subgroup
of patients.
Nevertheless, for many rehabilitative interventions, in partic-
ular those for long-term or chronic rehabilitation, robust data
or adequately controlled studies are lacking (Quinn et al., 2009):
e.g., comparisons between different training methods in current
use could not show that any particular physiotherapy or stroke
rehabilitation strategy is superior to another (Johansson, 2000).
Consequently optimal rehabilitation strategies can only be
defined if we understand the way in which training and the
rehabilitation protocol influences the neurobiology of the central
nervous system with priority on the aspects of timing, kind and
intensity of rehabilitative training. Measurable endpoint criteria
for rehabilitative outcome are required in order to achieve two
purposes: the adjustment of the ideal rehabilitative strategy to
the individual patient, and the choice of the optimal therapy
protocol.
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In this review we focus on mechanisms of spontaneous
recovery after stroke, on rehabilitative designs to enhance
plasticity, on growth promoting mechanisms with an emphasis
on anti-Nogo-A immunotherapy, and on the time windows of
rehabilitative training and pharmacological interventions and the
combination of both.
MECHANISMS OF SPONTANEOUS RECOVERY AFTER
STROKE—FROM HUMAN PATIENTS TO ANIMAL MODELS
For many years people have thought that the hardware of the
brain is that “hard”, that once an incident such as stroke happens,
brain areas and functions are lost forever. The old paradigm
of the adult CNS as a stable and static structure, consisting of
billions of nerve cells and circuits, has now been replaced by a
much more dynamic view of the CNS which includes processes
of growth, connectivity changes and areal remodeling that can
occur after CNS injury or stroke and plays an important role in
recovery and functional repair.
Spontaneous recovery is seen in stroke patients weeks to
months after the incident. However, due to variability across
subjects and across neurological domains efforts of summarizing
this process with precision have been frustrating. Among the
most obvious factors that contribute to the extent of spontaneous
recovery are infarct size, infarct location, age and pre-stroke dis-
ability (Cramer, 2008). Most spontaneous recovery tends to occur
within the first 3 months. While patients with milder deficits
achieve spontaneous recovery more quickly than patients with
more severe deficits, the pattern of spontaneous recovery can also
differ within the same patient for different functions (Cramer,
2008).
SPONTANEOUS RECOVERY OF SENSORIMOTOR FUNCTION IN HUMANS
Motor recovery has been among the most often examined because
motor impairments belong to the symptoms that are most fre-
quently and precisely diagnosed after stroke (Gresham et al., 1998;
Rathore et al., 2002; Langhorne et al., 2009). Motor impairment
can be regarded as a loss or limitation of function in muscle
control or movement or a limitation in mobility. It is a focus
of physiotherapy or occupational therapy in terms of stroke
rehabilitation (Langhorne et al., 2009). The natural history of
motor recovery is considerably heterogeneous: the first voluntary
movements can be seen anywhere from 6 to 33 days after a
hemiplegic stroke (Twitchell, 1951). The largest improvement
occurs in the first 30 days after stroke, though significant progress
is still found in patients with more severe deficits up to 90 days
after stroke (Wade, 1983; Duncan et al., 1992, 1994, 2005). Studies
on arm disability revealed that a maximum of function is reached
by 80% of the patients within 3 weeks and by 95% of patients
within 9 weeks (Nakayama et al., 1994). Still significant long-
term improvement is found if arm function starts to ameliorate
16 weeks after stroke onset (Broeks et al., 1999).
Insights into the underlying remodeling and re-organization
processes for functional recovery in the brain after stroke can
be obtained in human patients via functional neuroimaging
methods and brain mapping. These data suggest that recovery of
motor function after stroke leads to brain-wide modifications in
neuronal activity patterns and connectivity (Rehme and Grefkes,
2013). While initially tissue function and neurophysiological
responses are diminished within the injured primary neocortex,
cortical function increases over time (Marshall et al., 2000;
Calautti et al., 2001; Feydy et al., 2002; Grefkes and Fink, 2011).
In terms of good functional outcome one of the major correlates
is the degree of recovery of neurophysiological activity in the
affected primary cortical areas (Cramer, 2008). In other terms:
the best behavioral outcomes are associated with the greatest
restoration/remodeling of brain function towards the normal
state of organization (Ward et al., 2003; Zemke et al., 2003;
Ward, 2004; Murphy and Corbett, 2009). This is true even if
the post-stroke behavior is far from being identical to the pre-
stroke motor kinematics. In particular the extent of corticospinal
tract integrity is positively correlated to functional recovery as
revealed by transcranial stimulation of the motor cortex (M1)
and its efferents after stroke (Talelli et al., 2006). In general, if
an ischemic event occurs, those areas are recruited for structural
and functional modification which are either close or functionally
related and connected or both. Therefore, after a small stroke,
peri-infarct tissue is mainly involved that has similar function.
By contrast, after a large stroke, tissue that has similar functions
might be only found at more distant sites or in unaffected regions
of the contralateral hemisphere, where still enough capacity for
structural remodeling remains (Murphy and Corbett, 2009).
THE ROLE OF THE PREMOTOR AND CONTRALESIONAL MOTOR CORTEX
Which areas are activated and what they contribute in terms of
beneficial re-organization for functional recovery is still under
debate: a meta-analysis revealed that activation of premotor
areas and the contralesional primary M1 are consistent find-
ings (Rehme et al., 2012; Rehme and Grefkes, 2013). Interac-
tions between premotor areas and the lesioned primary M1 are
directly related to recovery and functional outcome. For example,
Johansen-Berg et al. (2002) showed that disruption of dorsal
premotor cortex activity by transcranial magnetic stimulation
(TMS) over both the ipsi- and contralateral hemisphere lead to
a deterioration of performance in stroke patients, but not in
healthy controls (Johansen-Berg et al., 2002). The exact role of
the activation of contralesional M1 is a subject to controversy:
longitudinal functional MRI studies revealed enhanced neuronal
activity in motor-related areas in both hemispheres after a large
stroke. But then during the first 12 months post-stroke this
activity returns to unilateral levels similar to those of healthy
controls for those patients with good motor recovery (Ward
et al., 2003). Remaining increased activity in the contralesional
M1 was often associated with poor outcome. Further studies
have demonstrated that inhibition of contralesional M1 activity
using repetitive TMS may lead to ameliorated motor perfor-
mance of the stroke-affected hand in the subacute and chronic
phase (Nowak et al., 2008; Takeuchi et al., 2012). In contrast,
Rehme et al. (2011) found that increases in contralesional M1
activity over the first 10 days after stroke correlate with the
amount of spontaneous motor improvement in initially more
impaired patients. These data suggest a supportive role for func-
tional recovery in the early phase after stroke for the contrale-
sional M1. In addition, disrupting contralesional M1 activity
with TMS resulted in a deterioration of motor-performance of
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the stroke-affected hand of stroke patients with capsula interna
infarcts (Lotze et al., 2006). A clear time-, size or lesion-
location- dependent influence of the contralesional M1, be it
either beneficial or harmful for functional recovery, remains to
be demonstrated.
CHANGES IN CORTICAL EXCITABILITY, LATERALIZED ACTIVATION AND
SOMATOTOPIC RE-MAPPING
For the above described remodeling and recruitment of areas
three main forms of reorganization have been described: (1)
increased cortical excitability in cortical regions distant from,
but connected to the stroke core; (2) reduced lateralized acti-
vation; and (3) somatotopic modifications within intact cortical
regions.
Increased activity, as a first form of reaction to stroke in
areas which before stroke formed a distributed network, has been
described many times (Brion et al., 1989; Chollet et al., 1991).
This phenomenon occurs in several cortical areas which include
motor, language, attention and visual functions (Cramer, 2008).
Widespread areas of cortical hyperactivity appear days after stroke
and diminish within months post incident (Ward, 2004). This
form of modification in cortical excitability is thought to be a
result of the down-regulation of the α1 γ -amino butyric acid
receptor subunit and a decrease in γ -amino butyric acidergic
inhibition (Neumann-Haefelin et al., 1998).
The second form of reaction to stroke—reduced lateralized
activation—reflects the increased activity in the contralesional
hemisphere, which reduces the extent of interhemispheric balance
as demonstrated in many stroke studies (Weiller et al., 1993; Seitz
et al., 1998). Reduced lateralized activation is a common brain
response not only seen in stroke but also in other neurological
contexts such as epilepsy, traumatic brain injury and multiple
sclerosis (Cramer, 2008). The exact function of this reduced
laterality remains to be elucidated: it may be just a subtype of
the described increased activity as described in the first form or
a passive event reflecting a reduced interhemispheric inhibition
resulting from the stroke. Another interpretation is that the
contralesional hemisphere has to take over functions that were
previously based in the ipsilesional hemisphere.
Both phenomena, increased cortical excitability and reduced
laterality, are related to spontaneous functional recovery (Cramer,
2008). Both are time dependent, increasing in the early weeks
after stroke and decreasing over months thereafter. This decrease
is greater among stroke patients with stronger functional recovery
while the persistent increased activity over both hemispheres
is greatest in those patients with the poorest outcome (Ward
et al., 2003; Cramer and Crafton, 2006). A relation to increased
susceptibility for seizures and phantom pain is possible.
The third response to ischemic injury—somatotopic
reorganization—implies that intact cortical regions—in
particular within the perinfarct area—reassign their functions
which they subserved before stroke and take over function, which
have been affected or lost by the ischemic event. Some studies
suggest that the largest degree of somatotopic reorganization is
associated with very large stroke injuries (Cramer and Crafton,
2006). Such map shifts occur in primary and secondary cortical
areas (Byrnes et al., 2001).
ANIMAL MODELS TO STUDY STROKE INDUCED CORTICAL
RE-ORGANIZATION ON THE ANATOMICAL AND MOLECULAR LEVEL
As studies in stroke patients have limitations, animal models of
stroke have been used to describe remodeling and reorganization
processes on the macro and molecular level. Although spon-
taneous recovery in animals tends to occur earlier (depending
on stroke size), imaging and mapping data show a number of
analogues between recovery in animals and in humans: connec-
tivity changes between sensorimotor cortex and deep grey matter
structures after middle cerebral artery occlusion (MCAO) in rats
were comparable to results in human stroke patients (van der
Zijden et al., 2007). fMRI studies concentrating on the affected
upper limb in rats have described a shift in laterality of activation
after stroke such that early after stroke, brain activation during
affected paw stimulation is mainly in the contralesional cortex,
later after stroke activity shifts toward the normal pattern, that
is the ipsilesional cortex (Dijkhuizen et al., 2001, 2003). Hsu and
Jones (2006) found that the larger the ischemic insult the stronger
the activity in the contralesional M1. In accordance with human
studies van Meer et al. (2012) could show that functional recovery
after MCAO in rats was correlated with the extent of preservation
or restoration of the ipsilesional corticospinal tract in combina-
tion with reinstatement of interhemispheric neuronal signal syn-
chronization and normalization of focal network organization.
New mapping methods allow describing somatotopic map
shifts in animals in greater detail: a recent study using light based
motor mapping in transgenic mice expressing light-sensitive
channelrhodopsin-2 before and after focal ischemic lesions of
the forelimb sensorimotor areas revealed decreased motor output
in the infarcted area and spatial displacement of sensory and
motor maps (Harrison et al., 2013). While strokes in sensory
cortex caused the sensory map to move into the M1, a stoke in
the M1 lead to a compensatory increase in peri-infarct cortical
motor output, but did not affect the position or excitability
of the sensory maps. In vivo 2-photon calcium or voltage sen-
sitive dye imaging furthermore opens up new possibilities to
study the reorganization of complex neuronal networks and their
functional relevance for stroke recovery (Winship and Murphy,
2008; Stetter et al., 2013). Anatomically, different studies have
demonstrated that map-shifts and re-mapping can be accom-
panied by axonal sprouting (Carmichael, 2003), and dendritic
spine turnover (Brown et al., 2008, 2009, 2010). Using different
tracing techniques, Starkey et al. (2012b) could show which
neurons take over when functional map shifts occur: if the fore-
limb M1 in rats was destroyed, neurons in the hindlimb area
took over to enable functional recovery of the forelimbs. This
functional shift was based on sprouting of new axon branches
from hindlimb corticospinal fibers into the cervical spinal cord,
followed by retraction of the original lumbar projecting axon
and thus a conversion of a hindlimb into a forelimb projecting
neuron.
Animal studies have also provided first insights on underly-
ing molecular changes. A unilateral infarct is associated with a
number of growth related processes, in some cases bilaterally.
These events include the induction of inflammatory markers,
grow-promoting and inhibiting genes, cell-cycle regulatory genes
and genes involved in synaptogenesis, dendritic branching and
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neuronal sprouting as reviewed elsewhere (Li and Carmichael,
2006; Popa-Wagner et al., 2007).
Three major phases of stroke reaction and repair are often
distinguished (Cramer and Crafton, 2006): the first epoch is
the acute reaction to the injury and takes place in the initial
hours when modifications become apparent in blood flow, edema,
metabolism and inflammation. A second epoch is related to
repair, starts in the first days post stroke and is on-going for
several weeks. During this epoch spontaneous recovery is seen and
endogenous repair related events reach their peak levels. The third
epoch begins weeks to months after stroke when spontaneous
recovery has reached a plateau and represents a stable but still
modifiable chronic phase.
On the molecular level stroke induces neuronal growth-
promoting genes in sequential waves post insult to initiate axonal
sprouting in the peri-infarct cortex, as initially shown in a rat
somato-sensory cortex (barrel field) infarct model (Carmichael
et al., 2005): in the early phase immediate early genes and growth
related mRNAs such as SPRR1 are induced 3–7 days after stroke.
Typical growth cone constituents such as GAP43, CAP23 and
MARCKS as well as the transcription factor c-Jun are expressed
from day 3 onward. Subsequently, the cell adhesion molecule
L1, cyclin-dependent kinase inhibitor p21 and embryonic tubulin
isoform alpha1 tubulin are induced, followed by the expression
of cytoskeletal reorganization genes such as SCG10 and SCLIP.
This pattern of growth gene expression described is unique
for axonal sprouting as a stroke response compared to expres-
sion profiles in neuronal development, peripheral or other CNS
injuries (Li et al., 2010). Furthermore, in an early response to
stroke (Mattson, 2008; Carmichael, 2012), several neurotrophic
factors such as brain-derived neurotrophic factor (BDNF), nerve
growth factor (NGF) and neurotrophin 3 (NT-3) as well as
fibroblast growth factor (FGF)-2 and insulin-like growth factor
(IGF-1), epidermal growth factor (EGF) and glial cell line-derived
neurotrophic factor (GDNF) are up-regulated. Each neurotrophic
factor species shows a different temporal and cellular distribution
pattern (Abe, 2000): while GDNF is mainly expressed by neurons,
CNTF induction was predominantly observed in astroglia of the
marginal region and VEDF gene expression was found in both
non-neuronal and neuronal cell types after stroke.
Axonal sprouting not only requires the induction of growth-
promoting programs within perinfarct neurons, but also a
reduction in the growth inhibitory environment (Carmichael,
2006): axonal growth inhibition in the adult CNS is mediated
through three general classes of proteins: myelin associated pro-
teins (Nogo-A, myelin-associated glycoprotein, oligodendrocyte
myelin glycoprotein), extracellular matrix proteins (e.g., chon-
droitin sulfate proteoglycans) and repulsive cues for growth cones
known mainly from development (e.g., ephrins, semaphorins).
Interestingly, messenger RNAs for the chondroitine sulfate pro-
teoglycans aggrecan, phosphacan and versican were found to
be induced later after stroke than the early and middle phase
of the growth-promoting gene expression. A small number of
growth inhibitory proteins including Nogo-A (Jiang et al., 2009),
ephrin A5, semaphoring IIIa and neuropilin 1 are induced in
the early phase, however, but down-regulation of Nogo receptor
components were also seen (Li et al., 2010).
Not only a temporal expression pattern of growth promoting
and inhibiting genes can be detected, but also the spatial dis-
tribution plays a role to induce the brain’s self-repair processes
at the right location: axonal sprouting e.g., in the peri-infarct
cortex takes place in a distinct environment close to but larger
than the glial scar. Thus, within the glial scar representing the
wall that separates the stroke core from the surviving per-infarct
tissue both, growth-promoting and growth inhibiting factors are
induced while the growth-permissive and peri-infact cortex shows
a reduction of the levels of growth inhibiting molecules such
as chondroitin sulfate proteoglycans. In contrast, neurotrophins
such as BDNF are highly up-regulated in the growth-permissive
penumbra und repressed in the stroke core (Lanfranconi et al.,
2011).
Taken together, the data on the time and space dependent
processes of intrinsic repair mechanisms after stroke suggest a
critical period or time window, in which the CNS recruits fac-
tors for plasticity that enhance functional recovery. One of the
most crucial questions that has to be addressed from a clinical
perspective is whether this period characterized by map shifts,
fiber growth and major functional and structural changes is also
the time window in which rehabilitative interventions should be
initiated. We now give an overview on rehabilitative and repair
strategies with an emphasis on timing, kind and intensity.
STRATEGIES TO ENHANCE PLASTICITY AFTER STROKE
GROWTH AND PLASTICITY ENHANCING TREATMENTS
Since the discovery of nerve growth factors and factors that pre-
vent neuronal outgrowth and survival, it became a goal in exper-
imental animal studies to apply or induce growth-promoting
factors and inhibit the inhibiting ones. Several preclinical studies
have examined various growth factors, hormones and cytokines
with the aim to enhance motor rehabilitation—including promi-
nent candidates such as NGF, glia (GDNF) and BDNF, IGF,
erythropoietin and the granulocyte colony-stimulating factor. All
have met with variable levels of success in animal models; some
initial clinical studies have started (The BDNF study group (Phase
III), 1999; Nagahara and Tuszynski, 2011).
In adult rats with large strokes, the administration of BDNF
resulted in improved recovery rates (Schäbitz et al., 2004), while
the beneficial effect of rehabilitation on the improvement of
forelimb function was prevented in animals treated with a BDNF
antisense oligonucleotide (Ploughman et al., 2009). The transla-
tion of these results into clinical trials remains challenging and
is a matter of safety concerns: in the case of BDNF applied as
a neuro-protective agent after stroke, the administration of very
large quantities would be necessary as well as repeated dosing to
overcome the limited amount of protein that reaches the CNS,
even with transient disruption of the blood-brain barrier after
stroke. The adverse effects of these high dosages have not been
extensively studied in animal models (Nagahara and Tuszynski,
2011). Furthermore, the largest clinical trial of erythropoietin
therapy revealed that, compared with placebo, erythropoietin
administration was associated with an increased risk of mortality
in patients with acute stroke (Ehrenreich et al., 2009).
Other experimental approaches to enhance the intrinsic regen-
eration ability of CNS axons include injecting cAMP analogs to
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influence intracellular signaling pathways (Hannila and Filbin,
2008), knock down of the protein synthesis inhibitor PTEN (Liu
et al., 2010) or blocking the small GTPase RhoA (Ellezam et al.,
2002).
Promising results have also been gained if inhibition of neu-
ronal plasticity and outgrowth was decreased either by: (1) digest-
ing growth restricting ECM proteoglycans with enzymes such
as chondroitinase ABC; (2) by blocking the growth inhibitory
protein Nogo-A; or (3) by grafting growth permissive cells.
The bacterial enzyme chondroitinase ABC digests the gly-
cosaminoglycan chains of the chondroitin sulfate proteoglycans
(CSPGs) which are part of the extracellular matrix and usually
up-regulated in astrocyctes and oligodendrocytes after CNS injury
(García-Alías and Fawcett, 2012). Chondroitinase ABC treatment
reduces scar formation and enhances axonal regeneration and
sprouting as first shown in several studies after experimental
spinal cord injury (Moon et al., 2001; Bradbury et al., 2002; Huang
et al., 2006). After stroke, chondroitinase ABC administration
promoted functional recovery (Hill et al., 2012; Starkey et al.,
2012a). Furthermore, Soleman et al. (2012) could demonstrate
that delayed chondroitinase ABC microinjections into the cervical
spinal cord induce localized plasticity of the forelimb sensori-
motor spinal circuitry without effects on the cortical peri-infarct
region.
Inhibition of Nogo-A signaling in animal models of stroke
The well-studied protein Nogo-A, a transmembrane protein of
about 1200 amino acids including a C-terminal 200 amino acid
reticulon (RTN) domain, is involved in several cellular and
molecular events contributing to the failure of CNS axons to
sprout and reconnect after CNS injury. Function-blocking anti-
bodies against Nogo-A, Nogo receptor (NgR1)-blocking pep-
tides, antibodies against the Nogo receptor subunit Lingo-1, or
pharmacological blockade of the signal transducer RhoA and
ROCK have been administered in various laboratories in dif-
ferent stroke and spinal cord injury models in rodents and
primates (Pernet and Schwab, 2012 for review). Enhancement
of behavioral recovery in a variety of sensory-motor tasks as
well as anatomical evidence of fiber growth, increased plasticity
and re-organization within the cortex, brain stem and spinal
cord have been reported (Zörner and Schwab, 2010 for review).
Despite different approaches to interrupt Nogo-A signaling, a
high degree of similarity in terms of functional recovery and
hardware changes in the CNS was found among research groups
and injury models. Acute intrathecal anti-Nogo-A antibody infu-
sion over 2 weeks after stroke, with an application starting early
after incident (Wiessner et al., 2003; Tsai et al., 2007), or delayed
application starting 9 weeks after stroke in adult rats (Tsai et al.,
2011) significantly improved forelimb function and was corre-
lated with a significant increase of midline crossing corticospinal
fibers originating in the unlesioned sensorimotor cortex. Robust
sprouting of new projections from contralesional brain regions
into subcortical structures as well as functional reorganization of
contralateral sensorimotor areas were reported after anti-Nogo-
A immunotherapy in rats (Markus et al., 2005; Cheatwood et al.,
2008). Those newly sprouting cortico-efferent axons terminated
in the red nucleus, pontine nuclei and spinal cord. A similar
effect was found by down-regulation of the Nogo receptor NgR
using adenovirus-mediated RNA interference (Wang et al., 2010)
or NgR or Nogo-A/B knockout mice (Lee et al., 2004). Anti-
Nogo-A immunotherapy was also associated with increases in
dendritic length, complexity, and spine density, both in the
lesioned and contralesional hemisphere (Papadopoulos et al.,
2006). Functional MR-imaging 8 weeks after unilateral MCAO
revealed adaptations in the somatosensory system of rats in the
anti-Nogo-A antibody treatment group (Markus et al., 2005).
Nevertheless anti-Nogo-A immunotherapy is not neuroprotective
in the sense that it would reduce stroke lesion size as reported
for anti-MAG immunotherapy (Irving et al., 2005). This opens
the therapeutic window for anti-Nogo-A immunotherapy in the
subacute and even chronic phase.
The described in vivo experiments represent essential
preclinical tests to validate the efficiency and safety of intrathecal
Nogo-A antibody administration. Three different anti-Nogo-A
antibodies (IN-1, 11C7, 7B12) have proved efficient in enhancing
axonal regeneration and outgrowth both in vitro and in vivo.
In collaboration with Novartis Pharma, a human anti-human
Nogo-A antibody has been developed and tested in extensive
toxicological studies with intrathecal antibody application in
rodents and primates. In a Phase I clinical trial1 with 52 acutely
injured para- and tetraplegic patients in Europe (European
Multicenter Study about Spinal Cord Injury, EMSCI2) and
Canada pharmacokinetics, safety, tolerance and dosing of
intrathecal delivery of the antibody were investigated. The
tolerance has been excellent without any adverse effects ascribed
to the anti-Nogo-A antibody (Abel et al., 2011). A placebo-
controlled Phase II clinical trial is currently in preparation.
Anti-Nogo antibodies are also in clinical trials or in preparation
for clinical trials for other neurological indications such as
multiple sclerosis and amytrophic lateral sclerosis (ALS). For
ALS GlaxoSmithKline (GSK) has also developed a humanized
anti-Nogo-A antibody (GSK1223249). In a Phase I clinical
trial, the intravenous injections of GSK1223249 were well
tolerated by the 76 patients enrolled in the study (Pradat et al.,
2011).
Several additional molecules restricting axonal growth in vitro
have been identified including ephrins, netrins, semaphorins
and oligodendrocyte myelin glycoprotein (OMgp; Schwab, 1990,
2010; Schwab et al., 1993). Their role in vivo after stroke has
to be evaluated. How much growth and plasticity of the adult,
stroke-injured CNS can be enhanced by single or combined
manipulations of growth promoting or inhibitory mechanisms,
and if there is a danger of chaotic growth and formation of wrong
connections is currently unknown.
Finally, grafting growth permissive cells, such as bone-marrow
mesenchymal cells, cord blood cells, fetal cells and embryonic
cells as a form of restorative therapy have been studied in animals
(Chopp and Li, 2002). E.g., cultivated bone-marrow stromal cells
from donor rats were stereotactically implanted into the peri-
infarct area in rats resulting in significant recovery of somatosen-
sory behavior. In a first small study, 5/30 stroke patients who
1http://clinicaltrials.gov/ct2/show/NCT00406016
2www.emsci.org
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received autologous bone-marrow mesenchymal cell transplanta-
tion showed beneficial effects in clinical stroke scores (Bang et al.,
2005). Such cell-based therapies could influence endogenous
neurogenesis, axonal sprouting and synaptogenesis in ischemic
brain tissue (Zhang and Chopp, 2009), although their effects may
be primarily immune-modulatory or neurotrophic. More detailed
and systematic studies are certainly needed.
REHABILITATIVE TRAINING IN CLINICAL AND EXPERIMENTAL STUDIES
The brain, including the motor system, learns by repetition
and training. Many basic mechanisms, however, are still poorly
understood, and rehabilitative training is largely evidence-based
medicine (European Stroke Organisation (ESO) Executive
Committee; ESO Writing Committee, 2008). Nevertheless there
are no generally accepted guidelines and no definite recommen-
dations concerning the timing, kind and intensity of rehabilita-
tive training. Clear end point data and randomized controlled
clinical trials are often lacking. Furthermore, stroke recovery is
a complex process that probably occurs through a combina-
tion of restoration, substitution and compensation of functions.
For this reason it has been also difficult to translate results
from rehabilitative studies in animals to recommendations for
rehabilitative schedules in human stroke patients. A major-
ity of clinical studies has been conducted in chronic stroke
patients (> 6 months after the stroke) as recruitment of these
patients was easier and baseline performance had stabilized
(Krakauer et al., 2012). These circumstances lead to functional
outcome measurements probably gained largely from compen-
satory techniques to improve skills for daily living. In contrast,
animal studies had a stronger focus on enhancing impairment
with more or less detailed analysis how much of the func-
tional recovery was restoration of baseline (motor) function or
compensation. Furthermore, the time courses of motor recov-
ery differ among animal and human studies: While recovery
in rodent models reaches its maximum around 4 weeks after
stroke, human stroke survivors complete most of their recovery
within 3 months (Dimyan and Cohen, 2011; Krakauer et al.,
2012).
Early vs. delayed training
A consensus exists that the effects of early training, whereby
“early” should be starting at 1–2 weeks in animals, not earlier (see
below), exceed effects of delayed training in terms of functional
recovery in both, animals and humans (Nudo, 2006; Murphy and
Corbett, 2009; Langhorne et al., 2010; Krakauer et al., 2012).
In animal studies, behavioral training after ischemic injury is
most effective for restoring behavioral performance, peri-infarct
neurophysiological maps and enhanced neuroanatomical changes
in the ipsi- and contralesional hemisphere when introduced
within the first week of injury (Nudo, 2006). In a rat MCAO
stroke model it was demonstrated that functional outcome and
dendritic branching patterns in the contralesional hemisphere
were restricted when rehabilitative training was initiated 14 and
30 days post insult (Biernaskie et al., 2004). In another study
by Hsu and Jones (2005), rats were trained in a skilled forelimb
reaching tasking starting 4 or 25 days post stroke. Reaching per-
formance was significantly enhanced in the early trained group.
In a small ischemic insult in M1 in squirrel monkeys delayed
training resulted in a large decrease in spared hand representation
during the spontaneous recovery period that persisted following
the delayed training (Barbay et al., 2006).
Concerns about initiating therapy too early following stroke
arose from studies where lesion size and cell death rate were seen
to be exaggerated after early excessive use of the impaired forelimb
in rats while the unimpaired forelimb was casted (Kozlowski et al.,
1996). One cause for increased lesion size following early excessive
limb training might be NMDA-mediated excitotoxicity in the
already hyperexcitable peri-infarct region (Humm et al., 1999). In
closer resemblance to clinical practice were animal studies, where
training or enriched rehabilitation was initiated a few days after
stroke. In these cases early intervention (1–3 days post stroke)
again was associated with increased cell-death but also with much
improved motor performance on the long-term (Risedal et al.,
1999; Farrell et al., 2001). Here, neuronal cell death may be part
of a pruning effect in which non- or dysfunctional neurons are
eliminated early due to a use-dependent selection. In summary,
the overall consensus from animal data is that initiating rehabili-
tative training 5 or more days after stroke is mostly beneficial and
has no adverse effects (Krakauer et al., 2012).
Constraint-induced movement therapy (CIMT), robot assisted
training and electrical devices to stimulate the rehabilitation
process
For human stroke patients two advanced rehabilitative
approaches have proven beneficial for functional outcome:
constraint-induced movement therapy (CIMT) and robot-
assisted training for upper limb function (Langhorne et al., 2009;
Liao et al., 2012; Mehrholz et al., 2012). Extensive preclinical
studies in rodents and primates have preceded both rehabilitative
strategies (Taub et al., 2002). When somatic sensation is surgically
abolished from a single forelimb in a monkey, the animal avoids
the usage of this forelimb in the free situation, but monkeys
can be induced to use the de-afferented extremity by restricting
movement of the intact limb continuously for a period of days.
This concept was successfully brought into the clinics when
chronic stroke patients wore a sling or cast on their less affected
arm during 90% of their waking hours for 14 days (Taub et al.,
1993). These patients showed a significant increase in the skill
and quality of movement as measured by two laboratory tests
and a much larger increase in real-world arm use over the
period of these 2 weeks than the unrestricted control group.
Two studies addressed the question of intensity and timing for
CIMT: In the VECTORS study (Dromerick et al., 2009), 52
stroke patients were randomized at about 10 days post stroke
to two levels of intensity of CIMT or standard upper extremity
therapy. Intense meant 3 h of CIMT vs. 2 h of shaping therapy.
After 90 days the motor outcome was worse for the more
intensive CIMT group, although there had been no difference
at 30 days. This result reflects the fact that too intensive CIMT
can turn into an adverse situation for both the patient and
the therapist. In the much larger EXCITE study (Wolf et al.,
2006) patients started CIMT therapy 3–9 months post stroke
and showed greater motor recovery than the usual care group.
In addition Lang et al. (2013) revealed that improvements
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in existing motor abilities were possible with both early (3–9
months post stroke) and delayed (15–21 months post stroke)
application of CIMT. However, significant reacquisition of the
ability to complete tasks was only detected with early CIMT
treatment.
A number of arm and also hand training robots have been
developed recently with the aim to allow very intense training
without continuous, costly physiotherapy assistance. In the most
modern set-ups, training devices are combined with interactive
video games that can boost the motivation of the patient for the
training and facility e.g., precision movements (e.g., grasping eggs
and putting them into a basket). The number of well controlled
and standardized outcome studies is still very limited. How-
ever, differences are discriminated between recovery of specific
movements under “laboratory conditions” and functional gains
for daily life activities (Mehrholz et al., 2012). Such studies are
needed to exactly know the specific advantages (and potential
drawbacks) of robot assisted rehabilitation in stroke (Aisen et al.,
1997; Balasubramanian et al., 2010; Mehrholz et al., 2012).
Therapeutic approaches which directly stimulate the PNS or
CNS electrically or by magnetic pulses may enhance neuroplastic-
ity during poststroke rehabilitation (Dimyan and Cohen, 2011).
Numerous research groups have examined the stimulation of the
CNS, specifically the primary M1, by noninvasive approaches
such as TMS and direct current stimulation as well as experi-
mentally in animals by the implantation of electrodes. Several
studies showed that an increase of the excitability in the stroke-
affected ipsilesional M1 by electrical devices resulted in improved
motor outcome (Hummel et al., 2005; Malcolm et al., 2007;
Ameli et al., 2009; Koganemaru et al., 2010). The mechanisms
of action of these techniques are under investigation but might
involve changes in synaptic activity, gene expression and increases
in neurotransmitter, receptor and neurotrophin levels (Dimyan
and Cohen, 2011) or even enhanced fiber sprouting (Martin,
2012). Understanding these mechanisms may provide the basis
for novel approaches using closed-loop brain machine interfaces
(BMIs) that define optimal stimulation parameters from a priori
developed experimental models and correctly modulate ionic
currents and extracellular electric fields to provoke and guide
plastic changes of the CNS (Gonzalez Andino et al., 2011).
COMBINATION OF DIFFERENT REPAIR AND REHABILITATION
STRATEGIES
To maximize the effectiveness of rehabilitative therapies after
stroke, it is critical to define when the brain is most responsive
to sensorimotor input or extrinsic application of plasticity pro-
moting reagents. This becomes particularly important if different
rehabilitative approaches are combined.
In one of the first proof of concept studies for a critical
period of heightened neuroplasticity, stroke rats were exposed
to an enriched environment in combination with daily sessions
of grasping training. The most significant gains in the recovery
of forelimb reaching ability were achieved when rehabilitation
was initiated early, i.e., 5 days after stroke as compared to 14
and 30 days after stroke. Recovery was associated with increased
dendritic branching of layer V M1 neurons in the unlesioned
hemisphere—a response that was not detected when rehabilita-
tion was delayed by 30 days (Biernaskie et al., 2004).
A few recent studies in which regenerative therapies and
rehabilitation have been combined have been conducted since
then. These experiments suggest that designing the combination
and their temporal pattern of administration are not going to
be trivial (García-Alías and Fawcett, 2012; Starkey and Schwab,
2012). The different experiments have revealed a beneficial com-
binatorial effect, a detrimental effect, no effect at all, or an effect
that depends on the relative timing of plasticity treatment and
rehabilitation.
Beneficial effects were described in spinal cord injury rat
models when agents against inhibitory molecules in the CNS
were combined with growth promoting reagents: García-Alías
et al. (2011) reported that the combination of Chondroitinase
ABC with neurotrophin NT-3 and an increased expression of the
NR2D subunit of the NMDA receptor resulted in better body
stability and interlimb coordination compared with the single
treatment groups. The behavioral data were correlated with the
highest number of sprouting axons in the spinal cord and multi-
synaptic responses in the motor-neurons. Similar results could be
found if anti-Nogo-A antibodies were combined with NT-3 and
the NMDA-NR2D subunit (Schnell et al., 2011). Furthermore, the
combinatorial treatment of acutely applied anti-Nogo-A antibody
followed by delayed Chondroitinase ABC treatment starting 3
weeks after spinal cord injury, and forelimb grasp training starting
at 4 weeks was much more effective in terms of functional recov-
ery, sprouting and axonal regeneration than the single treatments
(Rehme et al., 2011). In rats with large cortical strokes, inosine,
a substance which was shown to improve fine motor control
after stroke (Zai et al., 2009), augmented the effects of the Nogo
receptor blocker NEP1-40 in the restoration of skilled reaching
abilities in rats. Similar functional improvements were seen when
inosine was combined with environmental enrichment (Zai et al.,
2011).
Several recent experiments—mainly in spinal cord injury—
have combined growth-promoting agents with rehabilitative
training with somewhat different results: García-Alías et al. (2009)
investigated whether chondroitinase-induced plasticity combined
with physical rehabilitation promotes recovery of manual dexter-
ity in rats with cervical spinal cord injury. While CSPG digestion
combined with forelimb-specific rehabilitation lead to improved
manual dexterity, animals treated with chondroitinase ABC in
combination with environmental enrichment improved in ladder
walking but performed much worse in skilled forelimb tasks than
untreated control animals. In a second investigation by Maier
et al. (2009) adult rats with large but incomplete cervical spinal
cord injury received anti-Nogo A antibodies and simultaneous
daily forced treadmill training. The simultaneous rehabilitative
therapy clearly worsened the functional outcome compared with
either treatment alone. When the forced treadmill training was
delayed, however, for 2 weeks after the end of the antibody
treatment a very good functional outcome was obtained (Marsh
et al., 2011). In contrast to these results in spinal cord injured
rats, combination of Nogo receptor blockade with skilled forelimb
training in stroke lead to a greater degree of recovery than when
either of the treatments were applied alone (Fang et al., 2010).
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No additive or adverse effects were reported by Boyce et al.
(2007) when neurotrophins were combined with rehabilitative
training in spinal cord injured cats. Administration of pharma-
cological neuromodulators such as amphetamine and cholinergic
agonists in combination with rehabilitative training are a matter
of debate: early animal research had suggested a beneficial effect
of amphetamine in recovery of motor function after stroke which
could not be sufficiently reproduced in recent human and animal
studies (Krakauer et al., 2012). Only for the anti-depressant fluox-
etine, a serotonin-selective reuptake inhibitor, which was applied
from 9 days post stroke to 3 months in a human stroke study,
an impressive degree of increased motor recovery was found
when combined with rehabilitative training (Chollet et al., 2011).
For all these studies and their quite diverse outcomes, better
knowledge of the neurobiological phenomena and mechanisms
triggered by the injury, the spontaneous reaction of the nervous
tissue to it, and by the different pharmacological and behavioral
interventions is urgently required.
FUTURE DIRECTIONS FOR DESIGNING OPTIMAL
REHABILITATION SCHEDULES
How can we better understand the neurobiology of rehabilitation?
What can we learn from the above mentioned animal and clin-
ical studies to improve current rehabilitation schedules for the
best possible recovery after stroke? The presence of critical time
windows for the application of growth and plasticity promoting
agents and of training-dependent plasticity suggests that careful
consideration of rehabilitation onset times, tailored training to
the type and extent of stroke and the patient’s history are required.
Potential future rehabilitation schedules after stroke may therefore
include the following “3 step model” (Figure 1):
1. Determination of the metabolic and plastic status of the brain
by using state-of-the-art imaging technologies and metabolic
markers
2. Enhancement of the plastic status of the brain by the applica-
tion of growth and plasticity-promoting factors
3. Selection and stabilization of newly formed functional connec-
tions by rehabilitative training
One obstacle of the implementation of the optimal restorative
therapies is the heterogeneity of stroke as injury location and size
differ widely from one patient to another. The ability to assign
the right therapy to the right patient would maximize treatment
effects. Although clinical scores and a number of imaging meth-
ods exist for evaluating the state of the central nervous system and
its function after stroke as reviewed elsewhere (Burke and Cramer,
2013), these approaches are often insensitive, cost intensive and
have logistical difficulties. Nevertheless, neuroimaging is not only
essential for the establishment of acute stroke diagnosis but can
also serve as a powerful tool for the characterization of disease
FIGURE 1 | Schematic overview of the “3 step model”—as a possible
roadmap for designing future rehabilitation schedules: (1) determination
of the metabolic and plastic status of the brain by using state- of the art
imaging technologies (image taken by the Akashi Municipal Hospital, Japan)
and biomarker profiles in the blood and CSF; (2) enhancement of intrinsic
repair and plasticity mechanisms in the ispi- and contralesional hemisphere as
well as the spinal cord by application of growth and plasticity-promoting
factors such as anti-Nogo-A antibody or Chondroitinase ABC; and (3)
selection and stabilization of newly formed functional connections and
pruning of non-functional ones by rehabilitative training.
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progression and monitoring of the response to rehabilitative
interventions. Diffusion-weighted imaging (DWI) and perfusion-
weighted MRI (PWI) are widely available MRI modalities that
provide valuable information about the tissue characteristics of
the ischemic core but also of the tissue at risk in the penumbra
(Merino and Warach, 2010; Fisher and Bastan, 2012). Further
work is needed to optimize the characterization of penumbra
imaging for patient triage into adjusted treatment groups. In the
near future we expect to learn if penumbra imaging or other
early imaging features provide predictive value of critical time
windows in which therapeutic interventions should be initiated
or maintained and allow stratification of patients into groups for
specific types of therapies.
Biomarker profiles in blood and cerebrospinal fluid (CSF)
samples could bring a tremendous advance and are currently a
focus of genomic and proteomic profiling studies and of systems
biology in several laboratories (Stuart et al., 2010; Hemphill
et al., 2011; Whiteley et al., 2012). In this regard, a biomarker
or a specific combination and profile of biomarkers may not
only speed up diagnosis and initiation of acute stroke treatment
but may also help to classify and categorize patient groups for
prediction of outcome and target the right rehabilitative approach
to those stroke patients who would benefit the most.
Why do we suggest a temporal sequence of first enhancing the
plastic state by growth promoting agents followed by a phase of
rehabilitative training in our “3 step model”?
The current data suggest that the CNS reacts to the injury by an
activation of growth and plasticity mechanisms which, however,
seem to also represent a vulnerable phase in which forced activity
can be harmful: this phase includes a period of GABA-mediated
tonic inhibition, which may also be necessary in the first days
after the stroke to limit an expansion of the infarct size (Clarkson
et al., 2010), as well as homeostatic plasticity mechanisms, which
ensure that neurons receive an balanced amount of synaptic input
(Murphy and Corbett, 2009). Intrinsic growth and plasticity as
well as exogenous enhancement of growth will lead to the forma-
tion of a large number of new connections within and between
different areas of the injured CNS. In analogy to the situation in
early postnatal development, many of these connections may be
weak and imprecise. The functionally meaningful ones will now
have to be selected and stabilized, while the malfunctional ones
should be pruned, in the next, activity-dependent phase of the
recovery process.
In the last step of recovery that is based mainly on rehabilitative
training the spared and the new circuitry of the CNS is shaped by
selection and stabilization of functional connections and pruning
of the non-functional ones. Hebbian learning rules might play
a crucial role in this step in the sense that Hebbian plasticity
mechanisms redistribute synaptic strength to favor the wiring
of pathways that are coincidently active (Murphy and Corbett,
2009). Motor learning in development is a very protracted pro-
cess, requiring huge numbers of repetitions over a period of many
weeks and months. Much too less is known today on the optimal
time and intensity requirements for rehabilitation learning. To
distinguish optimal rehabilitation schedules from less beneficial
ones, strict criteria for functional outcome have to be defined that
discriminate compensation and substitution from real restoration
of previously impaired function. Much remains to be learned and
applied in this fascinating and medically most important field of
stroke rehabilitation at the interface between basic neuroscience
and clinical neurology.
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